Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Drug Metabolism and Personalized Therapy

Official journal of the European Society of Pharmacogenomics and Personalised Therapy

Editor-in-Chief: Llerena, Adrián

Editorial Board: Benjeddou, Mongi / Chen, Bing / Dahl, Marja-Liisa / Devinsky, Ferdinand / Hirata, Rosario / Hubacek, Jaroslav A. / Ingelman-Sundberg, Magnus / Maitland-van der Zee, Anke-Hilse / Manolopoulos, Vangelis G. / Marc, Janja / Melichar, Bohuslav / Meyer, Urs A. / Nair, Sujit / Nofziger, Charity / Peiro, Ana / Sadee, Wolfgang / Salazar, Luis A. / Simmaco, Maurizio / Turpeinen, Miia / Schaik, Ron / Shin, Jae-Gook / Visvikis-Siest, Sophie / Zanger, Ulrich M.


CiteScore 2018: 1.01

SCImago Journal Rank (SJR) 2018: 0.277
Source Normalized Impact per Paper (SNIP) 2018: 0.446

Online
ISSN
2363-8915
See all formats and pricing
More options …
Volume 26, Issue 2

Issues

Rhabdomyolysis-induced acute renal failure due to itraconazole and simvastatin association

Sébastien Roques / Maria Lytrivi / Daniel Rusu / Jacques Devriendt / David De Bels
Published Online: 2011-04-18 | DOI: https://doi.org/10.1515/dmdi.2011.106

Abstract

We present the case of an 82-year-old man admitted to our hospital for muscle weakness. He was under simvastatin 20 mg per day and was given pulse itraconazole therapy 8 days before the onset of symptoms for onychomycosis. He developed severe rhabdomyolysis inducing an acute renal failure necessitating renal replacement therapy. He eventually fully recovered. Given the possible concurrent use of simvastatin and itraconazole, awareness of this potential interaction is clinically important.

Keywords: acute renal failure; hepatic metabolism; itraconazole; pharmacological interaction; rhabdomyolysis; simvastatin

About the article

Corresponding author: David De Bels, Intensive Care Unit, Salle 92, Brugmann University Hospital, 4 Place A. Van Gehuchten, 1020 Brussels, Belgium Phone: +32 2 4779293, Fax: +32 2 4779294


Received: 2010-12-14

Accepted: 2011-03-11

Published Online: 2011-04-18

Published Online: 2011-04-18

Published in Print: 2011-08-01


Citation Information: Drug Metabolism and Drug Interactions, Volume 26, Issue 2, Pages 79–80, ISSN (Online) 2191-0162, ISSN (Print) 0792-5077, DOI: https://doi.org/10.1515/dmdi.2011.106.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Suraj P. Parihar, Reto Guler, and Frank Brombacher
Nature Reviews Immunology, 2018
[2]
Jonathan T. Davies, Spencer F. Delfino, Chad E. Feinberg, Meghan F. Johnson, Veronica L. Nappi, Joshua T. Olinger, Anthony P. Schwab, and Hollie I. Swanson
Lipid Insights, 2016, Volume 9, Page LPI.S37450
[3]
Ryan M. Rivosecchi, John A. Kellum, Joseph F. Dasta, Michael J. Armahizer, Scott Bolesta, Mitchell S. Buckley, Amy L. Dzierba, Erin N. Frazee, Heather J. Johnson, Catherine Kim, Raghavan Murugan, Pamela L. Smithburger, Adrian Wong, and Sandra L. Kane Gill
Annals of Pharmacotherapy, 2016, Volume 50, Number 11, Page 953
[4]
Anastazia A. Kei, Theodosios D. Filippatos, and Moses S. Elisaf
Expert Opinion on Drug Safety, 2016, Volume 15, Number 4, Page 559
[5]
Theodosios D Filippatos and Moses S Elisaf
Expert Opinion on Drug Safety, 2015, Volume 14, Number 9, Page 1481

Comments (0)

Please log in or register to comment.
Log in